FRANKFURT, Germany & BERLIN--(BUSINESS WIRE)--Nanostart (OTCQX: NASRY)-holding MagForce AG (XETRA: MF6), a leading medical technology company focusing on nanomedicine in oncology and Delrus Inc., a leading Russian medical product distribution company, announced today the signing of a Letter of Intent (LOI) between the two companies.
